skills/nvidia-bionemo/bionemo-agent-toolkit/drug-discovery-pipeline/Snyk

drug-discovery-pipeline

Pass

Audited by Snyk on Aug 13, 2026

Risk Level: LOW

Full Analysis

No issues detected.

Audit Metadata

Risk Level

LOW

Analyzed

Aug 13, 2026, 04:51 AM

Security Audit — snyk — drug-discovery-pipeline